Marimed INC Form 4 insider transactions

Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 53,571 Restricted Stock Units (RSUs) into common stock, with a portion withheld for tax obligations, as part of a pre-scheduled compensation event.

Marimed Inc.'s Chief Commercial Officer, Ryan Crandall, reported the vesting of 62,902 Restricted Stock Units and a subsequent disposition of shares to cover tax obligations on June 15, 2025.

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, reported the conversion of Restricted Stock Units into common stock and a subsequent sale of shares to cover tax obligations, as part of a routine insider transaction.

Marimed Inc.'s Chief Financial Officer, Mario Pinho, reported the vesting of 16,075 Restricted Stock Units (RSUs) into common stock and the subsequent disposition of 5,571 shares to cover tax withholding obligations.

Marimed Inc.'s President and CEO, Jon R. Levine, reported the vesting of Restricted Stock Units (RSUs) into common stock and a subsequent disposition of shares to cover tax withholding obligations.

Marimed Inc. Director Eva M.D. Selhub has reported the acquisition of 75,000 Restricted Stock Units as part of the company's director compensation program, vesting on June 12, 2026.

Marimed Inc. Director and 10% Owner, David R. Allen, was granted 75,000 Restricted Stock Units (RSUs) as part of the company's director compensation program.

Marimed Inc. Director Edward J. Gildea was granted 75,000 Restricted Stock Units as part of the company's director compensation program, vesting one year from the grant date.

Marimed Inc.'s Chief Commercial Officer, Ryan Crandall, reported the acquisition of 54,000 common shares through RSU conversion and the disposition of 18,711 shares for tax withholding, increasing his direct beneficial ownership.

Marimed Inc. Director Eva M.D. Selhub has increased her direct beneficial ownership in the company by 75,000 shares of common stock following the vesting of Restricted Stock Units.

Marimed Inc. Director David R. Allen has converted 75,000 Restricted Stock Units (RSUs) into common stock, increasing his direct beneficial ownership to 299,755 shares.

Marimed Inc. Director Edward J. Gildea converted 75,000 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 657,823 shares.

Marimed Inc. Director Kathleen Tucker has increased her direct beneficial ownership of the company's common stock by 75,000 shares through the conversion of previously granted Restricted Stock Units (RSUs).

Marimed Inc.'s Chief Operating Officer, Timothy Shaw, has reported his direct and indirect beneficial ownership of common stock, alongside the grant of 245,316 Restricted Stock Units set to vest in three installments through December 2025.

Director Eva Selhub reports acquisition and disposal of Marimed Inc. stock related to RSU conversion.

Director David R. Allen acquired 116,422 shares of Marimed Inc. common stock through the conversion of Restricted Stock Units (RSUs) on May 21, 2025.

Edward Gildea, a director of MariMed Inc., reports the acquisition and disposal of common stock and Restricted Stock Units (RSUs) on May 21, 2025.

Director Eva Selhub reports acquisition of 132,353 Restricted Stock Units (RSUs) in Marimed Inc. in lieu of cash payment for board service.

Director Edward J. Gildea reports the acquisition of 245,099 Restricted Stock Units (RSUs) of Marimed Inc. on May 15, 2025, convertible to common stock, in lieu of cash payment for board service.

Director David R. Allen reports the acquisition of 116,422 Restricted Stock Units (RSUs) from Marimed Inc. on May 15, 2025, convertible to common stock, in lieu of cash payment for board service.

Ryan Crandall, Chief Commercial Officer of Marimed Inc., reports the acquisition of 188,705 Restricted Stock Units (RSUs) that will vest in three equal installments later in 2025.

Mario Pinho, CFO of Marimed Inc., reports the acquisition of 48,226 Restricted Stock Units (RSUs) that will vest in three equal installments.

Jon R. Levine, President and CEO of Marimed Inc., reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, as well as adjustments to his direct and indirect beneficial ownership of common stock.

Chief Operating Officer Timothy Shaw reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, impacting his beneficial ownership of Marimed Inc. stock.

Jon Levine, President and CEO of Marimed Inc., reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, impacting his beneficial ownership of common stock.

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the acquisition and disposal of common stock and Restricted Stock Units (RSUs) on April 2, 2025.

Jon Levine, President and CEO of Marimed Inc., reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, impacting his beneficial ownership of common stock.

Mario Pinho, CFO of Marimed Inc., reports the acquisition and disposal of common stock and Restricted Stock Units (RSUs) on March 30, 2025.

Chief Operating Officer of Marimed Inc., Timothy Shaw, reports the vesting of Restricted Stock Units (RSUs) and subsequent tax withholding, along with holdings in a family trust.

Marimed Inc. CEO Jon Levine reports the vesting of restricted stock units and subsequent tax withholding, affecting his beneficial ownership of common stock.